- Home
- BHVN
BHVN
Biohaven Ltd.
as 09-17-2025 4:00pm EST
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | NEW HAVEN |
| Market Cap: | 1.5B | IPO Year: | 2017 |
| Target Price: | $52.13 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.65 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.79 - $55.70 | Next Earning Date: | 11-11-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 2195.07% |
Latest Biohaven Ltd. News
BHVN Breaking Stock News: Dive into BHVN Ticker-Specific Updates for Smart Investing
Investing.com
4 days ago
Biotech stocks: Who wins and who loses if RFK, Jr. goes
Motley Fool
a month ago
Why Biohaven Stock Zoomed More Than 6% Higher Today
Investor's Business Daily
a month ago
Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News?
MT Newswires
a month ago
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires
a month ago
Sector Update: Health Care Stocks Higher in Afternoon Trading
MT Newswires
a month ago
Biohaven Says US FDA Deems Advisory Committee Meeting No Longer Needed on Troriluzole
Benzinga
a month ago
Biohaven Advances Toward Potential First FDA-Approved Therapy For Spinocerebellar Ataxia, FDA Drops Advisory Meeting
BioPharma Dive
a month ago
FDA cancels adcomm on Biohaven drug; Catalent lays off staff
Compare BHVN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BHVN Biohaven Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.